يعرض 1 - 3 نتائج من 3 نتيجة بحث عن '"RM Portillo"', وقت الاستعلام: 0.34s تنقيح النتائج
  1. 1
    Abstract P3-06-12: Effect of TOP2A and cMYC gene copy number on outcome in a Phase II trial of adjuvant TC (Docetaxel/Cyclophosphamide) plus trastuzumab (HER TC) in HER2-positive early stage breast cancer

    المؤلفون: Yu-Sen Wang, Scot Sedlacek, A Lina, Mak Allison, Devchand Paul, Stephen E. Jones, M Crockett, C Stokoe, Steinberg, AM Favret, RM Portillo, Frankie A. Holmes, DL Lindquist, Ira Gore, Nicholas J. Robert, R. Collea, Joyce A. O'Shaughnessy

    المصدر: Cancer Research. 72:P3-06

    مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, Anthracycline, Cyclophosphamide, business.industry, Cancer, Phases of clinical research, medicine.disease, Regimen, Breast cancer, Docetaxel, Trastuzumab, Internal medicine, Medicine, business, medicine.drug

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::3978603a0246b3d19122c4bcb2802582
    https://doi.org/10.1158/0008-5472.sabcs12-p3-06-12

    View record in OpenAIRE

    أضف إلى المفضلة
  2. 2
    PD07-03: Phase II Trial of Adjuvant TC (Docetaxel/Cyclophosphamide) Plus Trastuzumab (HER TC) in HER2−Positive Early Stage Breast Cancer Patients

    المؤلفون: Mak Allison, Scot Sedlacek, Yunfei Wang, Ira Gore, C Stokoe, Nicholas J. Robert, RM Portillo, Devchand Paul, AM Favret, Frankie A. Holmes, Lina Asmar, R. Collea, DL Lindquist, M Crockett, Stephen E. Jones, Steinberg, Ruth Oratz, Joyce A. O'Shaughnessy

    المصدر: Cancer Research. 71:PD07-03

    مصطلحات موضوعية: Cancer Research, medicine.medical_specialty, business.industry, Cancer, Neutropenia, medicine.disease, Lower risk, Gastroenterology, Surgery, Regimen, Breast cancer, Oncology, Docetaxel, Trastuzumab, Internal medicine, medicine, business, Febrile neutropenia, medicine.drug

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::bfb401777db888df5560b4e54302a509
    https://doi.org/10.1158/0008-5472.sabcs11-pd07-03

    View record in OpenAIRE

    أضف إلى المفضلة
  3. 3
    Preliminary toxicity results of a phase II trial of adjuvant docetaxel/cyclophosphamide plus trastuzumab in HER2+ early stage breast cancer patients

    المؤلفون: Nicholas J. Robert, Scot Sedlacek, Lina Asmar, Devchand Paul, Frankie A. Holmes, M Crockett, R. Collea, RM Portillo, Joyce A. O'Shaughnessy, Ruth Oratz, Stephen E. Jones

    المصدر: Cancer Research. 69:2111

    مصطلحات موضوعية: Cancer Research, medicine.medical_specialty, education.field_of_study, Chemotherapy, Cyclophosphamide, business.industry, medicine.medical_treatment, Population, medicine.disease, Gastroenterology, Loading dose, Surgery, Regimen, Breast cancer, Oncology, Tolerability, Docetaxel, Internal medicine, medicine, business, education, medicine.drug

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::8cce6ed407052b643eba6bb501354b15
    https://doi.org/10.1158/0008-5472.sabcs-2111

    View record in OpenAIRE

    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS – أرسل هذا البحث بالبريد الإلكتروني – حفظ البحث – جدول التنبيهات: لا شيء